Terminated PHASE2 INTERVENTIONAL 1-arm NCT01851954

Pharmacokinetic Study of Clarithromycin in Very Low Birth Weight (VLBW)

Pharmacokinetic Study of Clarithromycin in Premature Infants With Safety Evaluation

Sponsor: Seoul National University Hospital

Conditions Ureaplasma/Mycoplasma Positive Very Low Birth Weight Infant

Updated 6 times since 2017 Last updated: Nov 17, 2014 Started: Feb 28, 2013 Primary completion: Apr 30, 2014 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

declined enrollment

Other terminated trials from Seoul National University Hospital

See all terminations from Seoul National University Hospital

This PHASE2 trial investigates Ureaplasma/Mycoplasma Positive and Very Low Birth Weight Infant and is currently terminated or withdrawn. Seoul National University Hospital leads this study, which shows 6 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE2
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE2

First recorded

Feb 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Seoul National University Hospital

Data source: Seoul National University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea